Genetic Tech gets capital raise from U.S. investors
Mar. 06, 2015 1:10 PM ETGenetic Technologies Limited (GENE)GENEBy: Douglas W. House, SA News Editor5 Comments
- Melbourne, Australia-based Genetic Technologies (GENE -20.8%) raises AUD$18.6M (US$14.3M) from U.S.-based investors via its offer of 3,333,333 American Depositary Shares (ADSs) representing 499,999,950 ordinary shares. Each ADS represents 150 ordinary shares.
- Net proceeds will fund the commercialization of BREVAGenplus, the company's refocus on the U.S. molecular diagnostics market and working capital.
Recommended For You
Comments (5)
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.
Lejun James Shao
14 Mar. 2015
May start another round of run similar to ADXS.
Patent News
06 Mar. 2015
comments not showing up
J
Jeffery Gass
08 Mar. 2015
ya they r gna b awhile before this one takes off again
Patent News
06 Mar. 2015
started a position on the dip
Verge Of Bankruptcy
06 Mar. 2015
That explains the recent pump & dump!